The MedStorm Pain Sensor offers precise measurement of real-time pain assessment for Neonates from 23 weeks to tailor the need for analgesia and anti-nociceptive drugs, to reduce side-effects from over and under medication. Improved pain management may lead to a reduction in the length of hospital stay and associated costs.
The suggested used cases are as follows: Postoperatively - Artificial ventilated – Asphyxiated.
The MedStorm Pain Sensor measures pure changes in skin conductance and is therefore not influenced by haemodynamic and respiratory instability or medications.
The MedStorm Pain Sensor offers precise measurement of real-time pain assessment for Neonates from 23 weeks to tailor the need for analgesia and anti-nociceptive drugs, to reduce side-effects from over and under medication. Improved pain management may lead to a reduction in the length of hospital stay and associated costs.
The suggested used cases are as follows: Postoperatively - Artificial ventilated – Asphyxiated.
The MedStorm Pain Sensor measures pure changes in skin conductance and is therefore not influenced by haemodynamic and respiratory instability or medications.
